The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

StocksUpdated•Originally published 30 April 2026•Updated 30 April 2026•

1 min read

Resmed Announces CFO Retirement and Names Aaron Bloomer as Successor

Key Facts

1Resmed announced CFO Brett Sandercock will retire on May 4, 2026, after 27 years with the company.

2Aaron Bloomer, formerly CFO at Exact Sciences, has been named as the successor.

Resmed Inc. has announced a long-term leadership transition for its CFO position, with veteran Brett Sandercock set to retire in May 2026 and Aaron Bloomer named as his successor. Alongside this transition, the company reported third-quarter profits that exceeded analyst estimates, driven by robust demand for its medical devices. This strong financial performance comes at a strategic time, potentially providing a boost as the stock has recently traded near 52-week lows. The extended transition period is designed to ensure organizational stability and a seamless transfer of financial responsibilities. Investors are now weighing the impact of the leadership shift against the backdrop of solid earnings growth in the healthcare equipment sector. The beat in Q3 results underscores the company's operational resilience during this period of executive change.

about 1 month ago

Version History

Version 1about 1 month ago

What changed: The story was updated to include ResMed beating Q3 profit estimates driven by strong medical device demand.